. Author manuscript; available in PMC: 2021 Jul 1.

Published in final edited form as: Am J Obstet Gynecol. 2020 Jan 15;223(1):99.e1–99.e9. doi: 10.1016/j.ajog.2019.12.270

Table 5.

Frequency and percentage of participants meeting the within-woman minimal clinically important change threshold for each DIVA domain, by intervention arm.

	Total (n=289)	Vaginal Estradiol (n=98)	Vaginal Moisturizer (n=97)	Dual placebo (n=94)
DIVA domain	n (%)	n (%)	n (%)	n (%)
Activities of daily living	162 (56%)	63 (64%)	53 (55%)	46 (49%)
Emotional well-being	166 (57%)	60 (61%)	60 (62%)	46 (49%)
Sexual functioning	176 (61%)	64 (65%)	55 (57%)	57 (61%)
Self-concept and body image	180 (62%)	66 (67%)	58 (60%)	56 (60%)